Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
BBOT: BridgeBio Oncology Therapeutics Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
BBOT
The Story
BBOT
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-45.0%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
0.0×
Current ratio
6.16×
BridgeBio Oncology Therapeutics Inc.
BBOT
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
BridgeBio Oncology Therapeutics Inc.
BBOT
NASDAQ
·
USD
·
Closed
$8.09
−4.82%
$8.09
−$0.41 (4.82%)
52W Range
14th
pctl
Volume
0.86×
avg
Mkt Cap
648.07M
USD
P/E
-1.4
TTM
Div Yield
–
ann
52W Range
14th
pctl
Volume
0.86×
avg
Market Cap
648.07M
USD
P/E Ratio
-1.4
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings